Alnylam Pharmaceuticals
ALNY
#443
Rank
HK$407.07 B
Marketcap
HK$3,081
Share price
1.00%
Change (1 day)
66.64%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: HK$407.07 Billion

As of December 2025 Alnylam Pharmaceuticals has a market cap of HK$407.07 Billion. This makes Alnylam Pharmaceuticals the world's 443th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$407.07 B70.83%
2024HK$238.28 B27.02%
2023HK$187.60 B-17.88%
2022HK$228.44 B44.45%
2021HK$158.14 B35.1%
2020HK$117.05 B16.33%
2019HK$100.62 B74.2%
2018HK$57.76 B-41.32%
2017HK$98.44 B295.12%
2016HK$24.91 B-59.87%
2015HK$62.08 B6.89%
2014HK$58.08 B82.76%
2013HK$31.78 B328.03%
2012HK$7.42 B174.54%
2011HK$2.70 B-16.76%
2010HK$3.24 B-43.16%
2009HK$5.71 B-27.78%
2008HK$7.91 B-14.39%
2007HK$9.24 B49.91%
2006HK$6.16 B208.73%
2005HK$1.99 B78.44%
2004HK$1.11 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

HK$407.07 Billion
by Nasdaq info icon info icon
HK$407.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Arrowhead Pharmaceuticals
ARWR
HK$71.49 B-82.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$617.38 B 51.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$16.58 B-95.93%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$8.09 B-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.39 B-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.019 T 396.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$911.36 B 123.88%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
HK$270.63 B-33.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel